US Patent 9248199 1:1 adducts of sickle hemoglobin
Patent 9248199 was granted and assigned to Global Blood Therapeutics on February, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+298 characters)
Article
Patent abstract
Provide herein are 1:1 adducts of sickle hemoglobin (HbS) and a compound of formula (I), as defined herein, suitable as modulators of HbS, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Brian W. Metcalf0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09248199 1:1 adducts of sickle hemoglobin US Patent 9248199 1:1 adducts of sickle hemoglobin
Infobox
Patent Number
092481990
Patent Number
92481990
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
092481990
Date of Patent
February 2, 2016
0Patent Application Number
141676320
Date Filed
January 29, 2014
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09248199 1:1 adducts of sickle hemoglobin
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09248199
Date of patent
February 2, 2016
Patent application number
14167632
Date Filed
January 29, 2014
Patent primary examiner
Find more entities like US Patent 9248199 1:1 adducts of sickle hemoglobin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
